MYR 4.33
(-1.59%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -4.37 Million MYR | 30.71% |
2022 | -6.3 Million MYR | 59.45% |
2021 | -15.55 Million MYR | -236.39% |
2020 | 11.4 Million MYR | -54.34% |
2019 | 24.97 Million MYR | -15.89% |
2018 | 29.69 Million MYR | -40.17% |
2017 | 49.62 Million MYR | -12.7% |
2016 | 56.84 Million MYR | -29.52% |
2015 | 80.65 Million MYR | -13.24% |
2014 | 92.96 Million MYR | -14.17% |
2013 | 108.31 Million MYR | -1.28% |
2012 | 109.71 Million MYR | -4.41% |
2011 | 114.77 Million MYR | 7.56% |
2010 | 106.7 Million MYR | 0.07% |
2009 | 106.62 Million MYR | 57.33% |
2008 | 67.77 Million MYR | 1215.96% |
2007 | -6.07 Million MYR | -1.47% |
2006 | -5.98 Million MYR | 23.31% |
2005 | -7.8 Million MYR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q4 | -4.37 Million MYR | 92.7% |
2023 Q2 | -6.29 Million MYR | 33.59% |
2023 Q3 | -59.88 Million MYR | -851.55% |
2023 FY | -64.97 Million MYR | -930.14% |
2023 Q1 | -9.47 Million MYR | -50.25% |
2022 FY | -6.3 Million MYR | 59.45% |
2022 Q4 | -6.3 Million MYR | -56.08% |
2022 Q3 | -4.04 Million MYR | -99.65% |
2022 Q2 | -2.02 Million MYR | 92.55% |
2022 Q1 | -27.15 Million MYR | -74.56% |
2021 Q2 | -4.01 Million MYR | -163.27% |
2021 Q4 | -15.55 Million MYR | -444.0% |
2021 Q3 | -2.85 Million MYR | 28.74% |
2021 FY | -15.55 Million MYR | -236.39% |
2021 Q1 | 6.34 Million MYR | -44.39% |
2020 Q3 | 14.1 Million MYR | -23.26% |
2020 FY | 11.4 Million MYR | -54.34% |
2020 Q1 | 21.49 Million MYR | -13.93% |
2020 Q2 | 18.38 Million MYR | -14.49% |
2020 Q4 | 11.4 Million MYR | -19.16% |
2019 Q4 | 24.97 Million MYR | 6.27% |
2019 FY | 24.97 Million MYR | -15.89% |
2019 Q1 | 30.42 Million MYR | 2.47% |
2019 Q2 | 29.68 Million MYR | -2.45% |
2019 Q3 | 23.49 Million MYR | -20.83% |
2018 Q4 | 29.69 Million MYR | -21.36% |
2018 FY | 29.69 Million MYR | -40.17% |
2018 Q3 | 37.75 Million MYR | -1.82% |
2018 Q2 | 38.45 Million MYR | -11.32% |
2018 Q1 | 43.36 Million MYR | -12.61% |
2017 FY | 49.62 Million MYR | -12.7% |
2017 Q4 | 49.62 Million MYR | 9.44% |
2017 Q1 | 52.14 Million MYR | -8.28% |
2017 Q2 | 48.34 Million MYR | -7.29% |
2017 Q3 | 45.34 Million MYR | -6.2% |
2016 Q4 | 56.84 Million MYR | -17.13% |
2016 FY | 56.84 Million MYR | -29.52% |
2016 Q1 | 73.39 Million MYR | -9.01% |
2016 Q2 | 69.46 Million MYR | -5.35% |
2016 Q3 | 68.59 Million MYR | -1.25% |
2015 Q3 | 83.7 Million MYR | -0.46% |
2015 Q4 | 80.65 Million MYR | -3.64% |
2015 Q2 | 84.08 Million MYR | -9.07% |
2015 Q1 | 92.47 Million MYR | -0.52% |
2015 FY | 80.65 Million MYR | -13.24% |
2014 Q4 | 92.96 Million MYR | -4.79% |
2014 FY | 92.96 Million MYR | -14.17% |
2014 Q2 | 101.87 Million MYR | -1.52% |
2014 Q1 | 103.44 Million MYR | -4.49% |
2014 Q3 | 97.64 Million MYR | -4.16% |
2013 Q2 | 115.9 Million MYR | 4.26% |
2013 Q3 | 113.79 Million MYR | -1.82% |
2013 Q4 | 108.31 Million MYR | -4.81% |
2013 FY | 108.31 Million MYR | -1.28% |
2013 Q1 | 111.17 Million MYR | 1.33% |
2012 Q2 | 119.03 Million MYR | -1.71% |
2012 Q4 | 109.71 Million MYR | -5.62% |
2012 FY | 109.71 Million MYR | -4.41% |
2012 Q1 | 121.1 Million MYR | 5.52% |
2012 Q3 | 116.24 Million MYR | -2.35% |
2011 Q4 | 114.77 Million MYR | 1.92% |
2011 Q3 | 112.61 Million MYR | 4.08% |
2011 FY | 114.77 Million MYR | 7.56% |
2011 Q2 | 108.19 Million MYR | 0.0% |
2010 FY | 106.7 Million MYR | 0.07% |
2010 Q3 | 107.47 Million MYR | 0.0% |
2010 Q4 | 106.7 Million MYR | -0.72% |
2009 Q4 | 106.62 Million MYR | 0.0% |
2009 FY | 106.62 Million MYR | 57.33% |
2008 FY | 67.77 Million MYR | 1215.96% |
2007 FY | -6.07 Million MYR | -1.47% |
2006 FY | -5.98 Million MYR | 23.31% |
2005 FY | -7.8 Million MYR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Duopharma Biotech Berhad | 278.34 Million MYR | 101.57% |